Solid Biosciences to Present at the 11th Annual World Orphan Drug Congress USA 2021
- Chief Operating Officer to discuss company’s advanced AAV gene therapy manufacturing capabilities and best practices for orphan drug development...
- Chief Operating Officer to discuss company’s advanced AAV gene therapy manufacturing capabilities and best practices for orphan drug development...
ATLANTA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the...
Real-world data published in Clinical Ophthalmology show the safety, efficacy, and durability of effect of OMNI for use in a...